2-amino-7-phosphonoheptanoic acid has been researched along with Brain Disorders in 2 studies
2-amino-7-phosphonoheptanoic acid: (D)-isomer active as an antagonist of N-methyl-D-aspartate excitation of central neurons; (L)-isomer inactive; RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarcz, R | 1 |
| Collins, JF | 1 |
| Parks, DA | 1 |
| Marret, S | 1 |
| Mukendi, R | 1 |
| Gadisseux, JF | 1 |
| Gressens, P | 1 |
| Evrard, P | 1 |
2 other studies available for 2-amino-7-phosphonoheptanoic acid and Brain Disorders
| Article | Year |
|---|---|
alpha-Amino-omega-phosphono carboxylates block ibotenate but not kainate neurotoxicity in rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Brain Diseases; Hippocampus; Ibotenic Acid; Kaini | 1982 |
Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions.
Topics: 2-Amino-5-phosphonovalerate; Alanine; Amino Acids; Animals; Brain; Brain Diseases; Embryonic and Fet | 1995 |